Rafael Amado, EVP of R&D and CMO at Allogene Therapeutics, Inc. (ALLO), sold 33,076 shares at $39.40 ($1.3M) on 2020-10-07, disclosed to the SEC on 2020-10-08.
Open-market sale of $1.3M ALLO by EVP of R&D and CMO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $39.40 | 16,538 | $652K | 50.0% |
| 2 | $39.40 | 16,538 | $652K | 50.0% |
| Total | $39.40 avg | 33,076 | $1.3M | 100% |
| Filing → |
| ZLAB | SELL | 2026-03-16 | $110K | — | Filing → |
| ZLAB | SELL | 2026-03-05 | $174K | — | Filing → |
| ZLAB | SELL | 2026-01-02 | $188K | — | Filing → |